Cargando…

A Differential Effect of Lovastatin versus Simvastatin in Neurodevelopmental Disorders

Detalles Bibliográficos
Autores principales:	Muscas, Melania, Seo, Sang S., Louros, Susana R., Osterweil, Emily K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433894/ https://www.ncbi.nlm.nih.gov/pubmed/32651266 http://dx.doi.org/10.1523/ENEURO.0162-20.2020

Ejemplares similares

Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model
por: Muscas, Melania, et al.
Publicado: (2019)

Perturbed proteostasis in autism spectrum disorders
por: Louros, Susana R., et al.
Publicado: (2016)

Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin
por: Vree, Tom B., et al.
Publicado: (2003)

Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome
por: Thomson, Sophie R., et al.
Publicado: (2017)

Clinical and Economic Outcomes of Conversion of Simvastatin to Lovastatin in a Group-Model Health Maintenance Organization
por: Billups, Sarah J., et al.
Publicado: (2005)

Cost-Effectiveness Analysis of Simvastatin and Lovastatin/Extended-Release Niacin to Achieve LDL and HDL Goal Using NHANES Data
por: Armstrong, Edward P., et al.
Publicado: (2004)

Biochemistry and Nanomechanical Properties of Human Colon Cells upon Simvastatin, Lovastatin, and Mevastatin Supplementations: Raman Imaging and AFM Studies
por: Beton, Karolina, et al.
Publicado: (2022)

Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
por: Ottenhoff, Myrthe J., et al.
Publicado: (2020)

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells
por: Glynn, Sharon A, et al.
Publicado: (2008)

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Whitehorn, James, et al.
Publicado: (2016)

Differential Effects of Lovastatin on Cisplatin Responses in Normal Human Mesothelial Cells versus Cancer Cells: Implication for Therapy
por: Shi, Yandong, et al.
Publicado: (2012)

Effects of Lovastatin on Brain Cancer Cells
por: Amadasu, Efosa, et al.
Publicado: (2022)

Structural basis for the biosynthesis of lovastatin
por: Wang, Jialiang, et al.
Publicado: (2021)

Generating truth from error: insights from neurodevelopmental disorders
por: Jha, Ashwani, et al.
Publicado: (2019)

Transdiagnostic research and the neurodiversity paradigm: commentary on the transdiagnostic revolution in neurodevelopmental disorders by Astle et al.
por: Fletcher‐Watson, Sue
Publicado: (2022)

Newborn screening for neurodevelopmental diseases: Are we there yet?
por: Chung, Wendy K., et al.
Publicado: (2022)

Microbial Production and Biomedical Applications of Lovastatin
por: Seenivasan, A., et al.
Publicado: (2008)

Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome
por: Seo, Sang S., et al.
Publicado: (2022)

The role of lovastatin in the attenuation of COVID-19
por: Karampoor, Sajad, et al.
Publicado: (2021)

Improved bioavailability through floating microspheres of lovastatin
por: Kumar, S., et al.
Publicado: (2011)

hnRNPH2 gain-of-function mutations reveal therapeutic strategies and a role for RNA granules in neurodevelopmental disorders
por: Kelvington, Benjamin A., et al.
Publicado: (2023)

Commentary: A longitudinal exploration of the effects of the COVID‐19 lockdowns for adolescents both with and without neurodevelopmental disorders – a reflection on Houghton et al. (2022)
por: Field, Charlotte
Publicado: (2022)

NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells
por: Savas, Sevtap, et al.
Publicado: (2011)

Lovastatin‐Mediated Changes in Human Tendon Cells
por: Kuzma‐Kuzniarska, Maria, et al.
Publicado: (2015)

Seeking biomarkers that predict neurodevelopmental impairment in preterm infants
por: Cascant-Vilaplana, Mari Merce, et al.
Publicado: (2021)

Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria
por: Francés, Lorena, et al.
Publicado: (2022)

Lovastatin Protects against Experimental Plague in Mice
por: Ayyadurai, Saravanan, et al.
Publicado: (2010)

Optimization of lovastatin production from Aspergillus fumigatus
por: Mouafi, Foukia E., et al.
Publicado: (2016)

Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation
por: Gaber, Dalia A
Publicado: (2020)

Respiratory morbidity and neurodevelopmental outcomes in infants born preterm: A complex web
por: Hibbs, Anna Maria
Publicado: (2022)

Effect of Lovastatin on Lipid peroxidation and total antioxidant concentrations in hemodialysis patients
por: Argani, Hassan, et al.
Publicado: (2004)

Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
por: Klawitter, Jelena, et al.
Publicado: (2010)

Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells
por: Kallas-Kivi, Ade, et al.
Publicado: (2016)

Isolation, Identification, and Characterization of an Unknown Impurity in Lovastatin EP
por: Belwal, Chandrakant, et al.
Publicado: (2014)

Lovastatin Production by Aspergillus sclerotiorum Using Agricultural Waste
por: Iewkittayakorn, Jutarut, et al.
Publicado: (2020)

Lovastatin as a supplement to mitigate rumen methanogenesis: an overview
por: Ábrego-Gacía, Amaury, et al.
Publicado: (2021)

Defining and Intervening on Cumulative Environmental Neurodevelopmental Risks: Introducing a Complex Systems Approach
por: Payne-Sturges, Devon C., et al.
Publicado: (2021)

Neurodevelopmental and neurobehavioral disorders
por: Patel, Dilip R., et al.
Publicado: (2020)

Sox2-Dependent 3D Chromatin Interactomes in Transcription, Neural Stem Cell Proliferation and Neurodevelopmental Diseases
por: Wei, Chia-Lin, et al.
Publicado: (2019)

Learning from Sisyphus: time to rethink our current, ineffective strategy on neurodevelopmental environmental toxicants
por: Takser, Larissa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mltde2jnbpqba39bme1fia9cs4